- Home
- Software Solutions
- Resources
- Corporate
A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma
Sponsors:
| Phases:
| |
| Indications | Acronym: RAD0503 | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 45 | |
Additional information about NCT00369512.